714 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

Sangamo Competitors or Alternatives

Sangamo's top competitors include uniQure, Regenxbio and Asklepios.

Unlock 12 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Sangamo's company profile

Sandy Macrae

President & CEO

68/100
480
$71.5M
$57.8M
  • $71.5M
    $57.8M
  • 480
    $71.5M
  • $57.8M
  • 68/100
  • 480
  • $71.5M
  • $57.8M
View ProfileView
1
Sangamo's Competitor - uniQure logo

Matthew Kapusta

CEO

83/100
209
$163.1M
$27.1M
  • $163.1M
    $27.1M
  • 209
    $163.1M
  • $27.1M
  • 83/100
  • 209
  • $163.1M
  • $27.1M
View ProfileView
2
Sangamo's Competitor - Regenxbio logo

Curran Simpson

President & CEO

83/100
370
$244.5M
$83.3M
  • $244.5M
    $83.3M
  • 370
    $244.5M
  • $83.3M
  • 83/100
  • 370
  • $244.5M
  • $83.3M
View ProfileView
3
Sangamo's Competitor - Asklepios logo

Kai Hankeln

CEO

72/100
50,000 - 100,000
$652M
$5B - 10B
  • $652M
    $5B - 10B
  • 50,000 - 100,000
    $652M
  • $5B - 10B
  • 72/100
  • 50,000 - 100,000
  • $652M
  • $5B - 10B
View ProfileView
4
Sangamo's Competitor - Dimension Therapeutics logo

Annalisa Jenkins

CEO

79/100
100 - 250
$191M
$5M - 25M
  • $191M
    $5M - 25M
  • 100 - 250
    $191M
  • $5M - 25M
  • 79/100
  • 100 - 250
  • $191M
  • $5M - 25M
View ProfileView
5
Sangamo's Competitor - InterMune logo

CEO

- -
250 - 500
$125M
$100M - 500M
  • $125M
    $100M - 500M
  • 250 - 500
    $125M
  • $100M - 500M
  • - -
  • 250 - 500
  • $125M
  • $100M - 500M
View ProfileView
Sangamo's top 15 competitors are uniQure, Regenxbio, Asklepios, Renova Therapeutics, Dimension Therapeutics, InterMune, Lysogene, Calimmune, Agilis Biotherapeutics, Sharp Edge, Recombinetics, Imara, Immunocore, bluebird bio and Spark Therapeutics. Together they have raised over 4.9B between their estimated 70.1K employees. Sangamo has 480 employees and is ranked 5th among it's top 10 competitors. The top 10 competitors average 4,411.

Sangamo VS uniQure

uniQure is perceived as one of Sangamo's biggest rivals. uniQure was founded in 1998 in Amsterdam, Noord-Holland. uniQure is in the Biotechnology field. uniQure generates $30.7M less revenue than Sangamo.

Sangamo VS Regenxbio

Regenxbio is Sangamo's #2 rival. Regenxbio is a Public company that was founded in 2008 in Rockville, Maryland. Regenxbio competes in the Biotechnology field. Compared to Sangamo, Regenxbio has 110 fewer employees.

Sangamo VS Asklepios

Asklepios is one of Sangamo's top competitors. Asklepios's headquarters is in Hamburg, Hamburg, and was founded in 1984. Like Sangamo, Asklepios also operates in the Pharmaceuticals & Biotechnology industry. Asklepios generates 9,229% of Sangamo's revenue.

Looking for similar companies to Sangamo?

Similar Companies

Biotechnology companies in Brisbane

See 37 companies 
Companies in Brisbane with revenue in $25-100M range

See 232 companies 
Pharmaceuticals & Biotechnology companies in Brisbane

See 54 companies 
Companies in Brisbane with employees in 100-250 range

See 473 companies 
Biotechnology companies with revenue in $25-100M range

See 862 companies 
Biotechnology companies with employees in 100-250 range

See 1,110 companies 
Biotechnology companies in San Francisco Bay Area

See 1,319 companies 
Pharmaceuticals & Biotechnology companies with revenue in $25-100M range

See 1,457 companies 
Pharmaceuticals & Biotechnology companies in San Francisco Bay Area

See 1,673 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Sangamo and Sangamo's Competitors

April 28, 2025FinanzNachrichten
One abstract accepted as platform presentation in prestigious Presidential Symposium, demonstrating potent combination of epigenetic regulation and cap...
April 29, 2025Citybizlist
RAHWAY, N.J.-(BUSINESS WIRE)-Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the start of... Read MoreThe post...
April 29, 2025Pharmabiz
Merck, known as MSD outside of the United States and Canada, announced results from the phase 3 KEYNOTE─689 trial evaluating Keytruda (pembrolizumab), ...
April 29, 2025Fox Business
Merck CEO Robert Davis spoke about the new state-of-the-art biologics center slated to be based in Wilmington, Delaware that could eventually provide t...
April 28, 2025Clinical Trials Arena
MSD has reported outcomes from a Phase III trial of Keytruda (pembrolizumab) for treating head and neck squamous cell carcinoma (LA-HNSCC). The post MS...

Frequently Asked Questions about Sangamo

  1. Who are Sangamo's top competitors?

    Sangamo's top 3 competitors are uniQure, Regenxbio, Asklepios.

  2. Who is similar to Sangamo?

    uniQure is the most similar to Sangamo. Regenxbio and Asklepios are also similar to Sangamo.

  1. Are Sangamo and uniQure competitors?

    Yes, uniQure is one of Sangamo’s top competitors.